Personalized Medicine a Reality
at Rapid Adoption Molecular (RAM) Lab

With support from the University Cancer Research Fund, the RAM (Rapid Adoption Molecular) Lab was developed to analyze multiple genes and create tests for use in personalized cancer medicine.

For example, Melanoma patients with a KIT gene mutation can now be identified and given drugs that work well in leukemia patients with similar types of mutations. The KIT mutation in melanoma was just discovered within the last several years, and the RAM lab has been making it available to the state's physicians.

For more information about the RAM Lab, contact Young Hu at 919-966-4408 or zhu@med.unc.edu. For more information about KIT gene mutation, contact Howard Parker at 919-966-4408 or HParker@unch.unc.edu.

Additional Information

• UNC-Chapel Hill a Recipient of The Cancer Genome Atlas Grant

• UNC Lineberger a Pioneer in Individualizing Therapy for Breast Cancer

• Personalized Medicine Helps Select Best Colorectal Cancer Therapies

Gearing up for the Fifth Annual UNC Conference on Melanoma

Specifically designed for a multidisciplinary view of the care of the melanoma patient, this course will examine common clinical issues and provide information to help with clinical decision-making.

The course will be held on Thursday, February 25 at the Friday Center in Chapel Hill, NC.

Read More & Register

Photo credit: stock.xchng